Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

MiMedx Group Q3 Adj. EPS $0.15 Beats $0.07 Estimate, Sales $113.725M Beat $94.144M Estimate

Author: Benzinga Newsdesk | October 29, 2025 03:01pm
MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.07 by 114.29 percent. This is a 114.29 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $113.725 million which beat the analyst consensus estimate of $94.144 million by 20.80 percent. This is a 35.30 percent increase over sales of $84.057 million the same period last year.

Posted In: MDXG


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist